Key result
Higher triglyceride-glucose index linked to ~91% greater CVD death risk in non-diabetic hypertension.
Why the study?
The study was conducted to explore the association of the triglyceride-glucose index with CVD death, stroke, MI, HF, and PAD in patients with non-diabetic hypertension.
Is a higher Triglyceride-glucose (TyG) index associated with an increased risk of cardiovascular diseases in patients with non-diabetic hypertension?
RCT (n=9,323)
Is a higher Triglyceride-glucose (TyG) index associated with an increased risk of cardiovascular diseases in patients with non-diabetic hypertension?
In patients with non-diabetic hypertension, a higher triglyceride-glucose index is a significant predictor of adverse cardiovascular outcomes including CVD death, heart failure, MI, stroke, and PAD.
Answers are grounded in this paper and cite their sources.
TyG index should not yet guide care in non-diabetic hypertension; leaves open its prognostic utility pending prospective validation.
This research intends to explore the association of the triglyceride-glucose (TyG) index with cardiovascular disease (CVD) death, stroke, myocardial infarction (MI), heart failure (HF) and peripheral arterial disease (PAD) in non-diabetic hypertension. This post hoc analysis uses data from a large-scale randomised controlled trial (RCT) study-Systolic Blood Pressure Intervention Trial (SPRINT), and we used Cox proportional hazards regression to explore the relationship between TyG and different CVDs. This longitudinal analysis of 9323 participants revealed a significant positive association between the TyG index and CVD death (HR 1.91, 95% CI 1.34, 2.73), HF (HR 1.43, 95% CI 1.05, 1.94), MI (HR 1.30, 95% CI 1.00, 1.69), stroke (HR 1.60, 95% CI 1.16, 2.21) and PAD (HR 1.78, 95% CI 1.30, 2.44). This positive correlation was consistently observed across different subgroups. Trend tests were significant for CVD death, heart failure, MI, stroke and PAD (p < 0.05). In non-diabetic hypertensive patients, a higher TyG index was associated with a higher risk of CVD (CVD death, stroke, HF, MI, PAD).
No takes yet. Share an insight, caveat, or question.
Xiao et al. (2025) conducted an RCT in Non-diabetic hypertension (n=9,323). Triglyceride-glucose (TyG) index was evaluated on CVD death (HR 1.91, 95% CI 1.34-2.73, p=<0.05). A higher triglyceride-glucose index was associated with increased risk of CVD death, heart failure, MI, stroke, and PAD in non-diabetic hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: